Prof. Dr. Luis F B B Feitoza | Clinical Sciences | Best Researcher Award

Prof. Dr. Luis Felipe Feitoza | Clinical Sciences | Best Researcher Award

Prof. Dr. Luis Felipe Feitoza, Kansas State University, United States

Dr. Luis Feitoza is a seasoned veterinarian and academic with a PhD in Veterinary Medicine & Pathobiology. 🐄 He specializes in bovine diagnostics, ruminant nutrition, and feedlot management. 🇺🇸🇧🇷 Trained in Brazil and the U.S., he has served as a Clinical Assistant Professor and research consultant, mentoring graduate students and leading veterinary research. 📊 He’s published on cardiac physiology and drug toxicity, and holds certifications in veterinary ultrasound and data analytics. 🏆 Awarded for both scientific and wildlife photography, he’s also a licensed drone pilot and multilingual communicator.

Publication Profile

Orcid

Google Scholar

🎓 Educational Background

Prof. Dr. Luis F.B.B. Feitoza holds a PhD in Veterinary Medicine & Pathobiology (2023–2024) from Kansas State University 🐄, focusing on veterinary diagnostics and ruminant nutrition. He also earned a Graduate Certificate in Applied Statistics (2018–2022) 📊 and pursued doctoral studies in Animal Sciences emphasizing beef cattle nutrition. Earlier, he received his DVM from the Federal Rural University of Rio de Janeiro (2012–2017) 🇧🇷. Dr. Feitoza also trained at UC Davis in muscle physiology 🧬 and was a visiting scholar at the University of Wisconsin-River Falls (2014–2015) 🇺🇸, where he also completed an English language program

🔬 Research & Work Experience

Prof. Dr. Luis F.B.B. Feitoza currently serves as Graduate School Faculty and Clinical Assistant Professor at the Beef Cattle Institute, Kansas State University 🐂 (2024–present), where he teaches bovine medicine and manages the Feedlot Clinical Rotation. Since 2017, he has worked as a Veterinary Research Consultant across Brazil and the USA 🌎, focusing on herd health, ultrasound diagnostics, and interdisciplinary R&D projects. His previous roles include Research Assistant and Doctorate Researcher (2023–2024), conducting clinical trials, laboratory assays, and data analysis 🔬📈. His work bridges diagnostics, internal medicine, and animal health innovation.

📚 Teaching Experience

Prof. Dr. Luis F.B.B. Feitoza has an extensive teaching background in veterinary and animal sciences 🐄. In 2025, he coordinated the Feedlot Clinical Rotation and lectured on agricultural communication at Kansas State University 🎓. His earlier roles as a Teaching Assistant included Equine Exercise Physiology and Horse Science (2019), where he focused on muscle physiology and equine nutrition 🐎. He also contributed to undergraduate research training (2018) and taught Animal Physiology at UFRRJ in Brazil (2013–2017) 🧬. His hands-on, student-focused approach emphasizes clinical knowledge, research skills, and cross-cultural communication.

🏆 Awards & Recognitions

Prof. Dr. Luis F.B.B. Feitoza has earned multiple accolades recognizing both his scientific and creative contributions 🎖️. He won first place at the IV Annual Meeting of Scientific Initiation (2016) for his work on maternal diet and offspring heart health 🫀. In 2014, he received Honorable Mention at the I Panamerican Congress of Physiological Sciences for research on cardiac adrenoreceptor expression in rats 🧪. Additionally, his photography earned him first and second place awards in the “Outdoor Recreation” and “Other Species” categories in Wild about Kansas by Kansas Wildlife Magazine in 2018

🔬 Research Focus

Prof. Dr. Luis F.B.B. Feitoza’s research spans across veterinary diagnostics, cardiotoxicology, ruminant nutrition, and parasitology 🐄🧬. His work includes studying drug-induced cardiac dysfunction using proteasome and mitochondrial pathways 🫀🧪, nutritional strategies like molasses-based supplementation to improve cattle health 🌾🥩, and parasitic infestations in exotic and wild animals, including first reports of tick species on emus 🦠🦢. He integrates statistical modeling, field diagnostics, and clinical trials to investigate animal health and performance. His interdisciplinary approach bridges veterinary science, physiology, and livestock management, making his research crucial for both animal welfare and agricultural efficiency

Publication Top Notes

📖 Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and heartsInternational Journal of Cardiology, 📅 2016 | 🔗 DOI: 10.1016/j.ijcard.2016.08.233 | 📥 Cited by: 77
💊🧬🫀

📖 Ticks in wild animals at a resort and the first documentation of Amblyomma sculptum infesting Emu (Dromaius novaehollandiae)Revista Brasileira de Parasitologia Veterinária, 📅 2019 | 🔗 DOI: 10.1590/s1984-296120180082 | 📥 Cited by: 9
🦠🦙🌿

📖 PSII-3 Effect of molasses-based block supplementation on cattle fed endophyte-infected Tall Fescue (Festuca arundinacea) seedJournal of Animal Science, 📅 2019 | 🔗 DOI: 10.1093/jas/skz122.400

📖 Effect of Molasses-Based Block Supplementation on Performance and Welfare of Cattle Fed Infected Tall Fescue seedJournal article, 📅 2019 | 🔗 DOI: 10.13140/RG.2.2.27430.37442/1

📖 Associations Between Thoracic Ultrasound Chute-Side Evaluations and 60-Day Outcomes in Feedyard CattleVeterinary Sciences, 📅 2025 | 🔗 DOI: 10.3390/vetsci12040369

📖 Molasses-Based Block Supplements for Cattle Fed Endophyte-Infected Tall Fescue: Growth & BiomarkersAnimals, 📅 2025 | 🔗 DOI: 10.3390/ani15050717

📖 Targeted durations of tylosin phosphate on liver abscesses in feedlot cattleApplied Animal Science, 📅 2025 | 🔗 DOI: 10.15232/aas.2024-02574

📖 Targeted thoracic ultrasonography for diagnosing interstitial pneumonia in feedyard cattleAmerican Journal of Veterinary Research, 📅 2025 | 🔗 DOI: 10.2460/ajvr.24.08.0233

📖 Thoracic Ultrasound in Cattle: Methods, Diagnostics, and PrognosticsVeterinary Sciences, 📅 2025

📖 greatOplus (Extruded Flaxseed & Nannochloropsis) Improves Cattle PerformanceKAES Research Reports, 📅 2025

📖 Histologic Characterization of Pulmonary Lesions in Feedlot Cattle MortalitiesConference Poster, 📅 2024 | 🔗 DOI: 10.13140/RG.2.2.25296.21766

📖 Viability of drone mapping in artisanal fisheries – Sepetiba Bay, BrazilCiência Rural, 📅 2024 | 🔗 DOI: 10.1590/0103-8478cr20230167

Julio César Fernández Travieso | Clinical Pharmacology | Best Researcher Award

Prof. Dr. Julio César Fernández Travieso | Clinical Pharmacology | Best Researcher Award

Prof. Dr. Julio César Fernández Travieso, National Centre for Scientific Research, Cuba

Prof. Dr. Julio César Fernández Travieso is a distinguished Cuban pharmaceutical scientist and Head of the Clinical Trials Unit at the National Centre for Scientific Research in Havana. He earned his BSc in Pharmaceutical Sciences in 1996 and completed his PhD in 2003. As a Senior Researcher and Full Academician of the Cuban Academy of Sciences, he has made significant contributions to the clinical development of natural-origin pharmaceuticals. With over 150 scientific publications and more than 120 conference presentations, his work has had a wide-reaching impact on experimental pharmacology and clinical research in Cuba.

Publication Profile

Scopus

Orcid

🎓 Education

Prof. Dr. Fernández Travieso completed his Bachelor of Science in Pharmaceutical Sciences from Havana University in 1996. He pursued advanced academic training and was awarded a PhD in Pharmaceutical Sciences in 2003. His education provided a comprehensive foundation in experimental pharmacology, pharmaceutical formulation, and clinical research methodologies. These qualifications enabled him to lead major clinical studies and serve in senior research roles. His academic background is firmly rooted in the development of therapeutics derived from natural sources, particularly those innovated in Cuba.

💼 Experience

Dr. Julio César Fernández Travieso currently serves as the Head of the Clinical Trials Unit at the National Centre for Scientific Research, Havana. With a career spanning over two decades, he has led multiple Phase I–IV clinical trials for novel therapeutics developed in Cuba. He is a Senior Investigator specializing in Clinical Pharmacology and has contributed to drug development, safety monitoring, and pharmacodynamic studies. His leadership has enabled the translation of research into approved therapeutic products. He also holds the title of Full Academician of the Cuban Academy of Sciences.

🏅 Awards and Honors

Prof. Dr. Fernández Travieso has received numerous national and international recognitions for his work in pharmaceutical sciences and clinical research. Several of his more than 120 scientific presentations have earned awards at global conferences. His appointment as a Full Academician of the Cuban Academy of Sciences highlights his standing in the scientific community. These honors reflect his role in advancing Cuba’s pharmaceutical innovation, particularly in clinical evaluation and development of natural products. His contributions have positioned him as a scientific leader in Latin America’s biomedical research landscape.

🔍 Research Focus

Dr. Fernández Travieso’s primary research interest lies in experimental pharmacology and conducting Phase I–IV clinical trials of natural-origin pharmaceuticals. He has played a pivotal role in evaluating and validating Cuban-developed products such as Policosanol, Abexol, Prevenox, Vasoactol, and Palmex. His work bridges laboratory pharmacology and clinical application, ensuring rigorous scientific evidence supports therapeutic claims. His research addresses chronic conditions like cardiovascular and metabolic disorders using innovative natural compounds. He also explores drug safety, efficacy, and pharmacokinetics in human populations.

Publication Top Notes

  • Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double-Blind, Multicentre Study 🧑‍⚕️, 2025

  • Comparative Study of the Efficacy and Safety of the Ozonated Sunflower Oil, Ketoconazole and Terbinafine in Patients with Dermatophytosis 💊, 2024

  • Beeswax Alcohol Prevents Low-Density Lipoprotein Oxidation and Demonstrates Antioxidant Activities in Zebrafish Embryos and Human Subjects: A Clinical Study 🧬, Cited by: 6, 2024

  • Effects of Policosanol in Patients with Metabolic Syndrome: A Six-Month Study 💉, Cited by: 6, 2020

  • Efficacy and Tolerability of Roystonea Regia Lipid Extract (D-004) and Terazosin in Men with Symptomatic Benign Prostatic Hyperplasia: A 6-Month Study 🔬, Cited by: 7, 2019

  • Concomitant Use of Policosanol and Antiplatelet Drugs in Older Patients 💊, 2019

  • Non-Cardioembolic Ischemic Stroke Hypertensive Patients, A Therapeutic Hope. Reply 🧠, 2019